GGrantIndex
Sort

27,075 grants matching cholesterol

ELEXSYS E500 CW EPR SPECTROMETER

$468,630
Jack H Freed · Cornell University · S10 · FY2010 · RR

EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY

$468,623
Ira Jay Goldberg · Columbia University Health Sciences · R01 · FY2012 · HL

EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY

$468,623
Ira Jay Goldberg · Columbia University Health Sciences · R01 · FY2011 · HL

Implications of midlife alcohol use for risk of dementia in male and female twins: Unique contributions and interactions with APOE4

$468,534
Susan E Luczak · University Of Southern California · R21 · FY2024 · AG

Intralumental Effect on Cholesterol Absorption/Synthesis

$468,484
James E. Heubi · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · DK

Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery

$468,467
Frank W Logerfo · Beth Israel Deaconess Medical Center · R01 · FY2015 · HL

Role of ABCG5 and ABCG8 in Sterol Metabolism

$468,454
Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2017 · HL

Role of ABCG5 and ABCG8 in Sterol Metabolism

$468,454
Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2016 · HL

Role of ABCG5 and ABCG8 in Sterol Metabolism

$468,454
Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2013 · HL

Cognitive Screening Made Easy for Primary Care Providers

$468,250
Joshua Tsukang Chang · University Of Texas At Austin · R33 · FY2025 · AG

Lipoprotein Structure and Apoprotein Conformation

$468,193
David Atkinson · Boston University Medical Campus · P01 · FY2010 · HL

Clinical Investigations of Smith-Lemli-Opitz Syndrome

$468,184
Forbes Porter · Child Health And Human Development · Z01 · FY2007 · HD

THE ATHEROPROTECTIVE EFFECTS OF SR-BI

$468,138
Massachusetts Institute Of Technology · R01 · FY2003 · HL

Integrating genomics and gene expression analyses to map CVD-associated loci

$468,074
Yoav Gilad · University Of Chicago · R01 · FY2012 · HL

TERPENE CONDENSATION REACTIONS

$468,071
University Of Utah · R37 · FY2004 · GM

A lipid-induced RNA-binding protein in atherosclerosis

$468,031
Paul C. Dimayuga · Cedars-Sinai Medical Center · R01 · FY2021 · HL

Project 2: Dyslipidemia and Atherosclerosis Regression

$467,855
Ira Jay Goldberg · University Of Washington · P01 · FY2015 · HL

Development of a Liposome Doxorubicin Product Drug Release Assay

$467,811
Peter Working · Zoneone Pharma, Inc. · U01 · FY2013 · FD

A Sphingomyelin Hydrolase Regulates the Late Stages of HIV Assembly and Budding

$467,771
Norman J Haughey · Tulane University Of Louisiana · R01 · FY2025 · MH

Interaction of Atherogenic Lipoproteins with Macrophages

$467,636
Ira A Tabas · Columbia University Health Sciences · R01 · FY2009 · HL

A novel role of cholesterol and SR-BI in adipocyte biology

$467,561
Chieko Mineo · Ut Southwestern Medical Center · R01 · FY2024 · DK

Isoprostane Products and HDL Dysfunction

$467,557
L Jackson Roberts · Vanderbilt University · P01 · FY2015 · HL

Multifactor Risk Reduction for Optimal Management in Peripheral Arterial Disease

$467,523
Roberta K Oka · University Of California, San Francisco · R01 · FY2009 · NR

Antigen Specific Responses to Borrelia

$467,492
Jorge L. Benach · State University New York Stony Brook · R56 · FY2015 · AI

GPR30 and hepatic cholesterol metabolism

$467,461
David Q Wang · Albert Einstein College Of Medicine · R01 · FY2020 · DK